MTHFS
Basic information
Region (hg38): 15:79833585-79897379
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination | AR | Neurologic | Individuals have been described with refractory seizures and recurrent episodes of hyperthermia, which responded to lamotrigine; A combination of oral L-5-methyltetrahydrofolate and intramuscular methylcobalamin has been described as resulting in mild functional improvements | Biochemical; Neurologic | 30031689 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination (2 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTHFS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 20 | 27 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 2 | |||||
Total | 2 | 1 | 21 | 11 | 5 |
Highest pathogenic variant AF is 0.0000394
Variants in MTHFS
This is a list of pathogenic ClinVar variants found in the MTHFS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-79845217-G-A | Uncertain significance (Mar 01, 2022) | |||
15-79845218-T-C | Benign (Feb 03, 2025) | |||
15-79845222-C-T | Likely benign (Jun 26, 2024) | |||
15-79845230-C-T | Benign (Nov 03, 2024) | |||
15-79845257-C-T | Uncertain significance (May 22, 2024) | |||
15-79845258-G-A | Likely benign (Jun 03, 2022) | |||
15-79845306-C-G | Likely benign (Oct 06, 2023) | |||
15-79845338-G-A | Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination | Likely pathogenic (Apr 30, 2019) | ||
15-79845388-C-T | Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination | Conflicting classifications of pathogenicity (Dec 22, 2023) | ||
15-79845402-G-A | MTHFS-related disorder | Benign (Oct 10, 2024) | ||
15-79845447-G-A | Likely benign (Apr 07, 2022) | |||
15-79889094-T-C | Uncertain significance (Aug 03, 2022) | |||
15-79889095-G-A | Uncertain significance (May 12, 2022) | |||
15-79889113-C-T | Uncertain significance (Nov 05, 2024) | |||
15-79889117-C-G | Likely benign (Oct 01, 2024) | |||
15-79889137-G-A | Uncertain significance (Aug 04, 2023) | |||
15-79889152-G-A | Uncertain significance (Oct 22, 2024) | |||
15-79889156-T-A | Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination | Pathogenic (Sep 09, 2021) | ||
15-79889179-G-A | Uncertain significance (May 16, 2022) | |||
15-79889189-T-C | Uncertain significance (Aug 31, 2022) | |||
15-79889221-C-T | not specified | Conflicting classifications of pathogenicity (Nov 05, 2024) | ||
15-79889222-G-A | Uncertain significance (Jul 02, 2022) | |||
15-79889227-C-T | not specified | Uncertain significance (Mar 03, 2025) | ||
15-79889228-G-A | Uncertain significance (Aug 31, 2022) | |||
15-79889252-G-A | Pathogenic (Mar 11, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTHFS | protein_coding | protein_coding | ENST00000258874 | 3 | 63795 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000258 | 0.556 | 125721 | 0 | 27 | 125748 | 0.000107 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.553 | 97 | 114 | 0.854 | 0.00000598 | 1323 |
Missense in Polyphen | 37 | 45.36 | 0.8157 | 526 | ||
Synonymous | -0.436 | 47 | 43.3 | 1.08 | 0.00000230 | 389 |
Loss of Function | 0.504 | 6 | 7.49 | 0.801 | 5.01e-7 | 79 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000206 | 0.000206 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Contributes to tetrahydrofolate metabolism. Helps regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of purines, thymidine and amino acids. Catalyzes the irreversible conversion of 5-formyltetrahydrofolate (5-FTHF) to yield 5,10- methenyltetrahydrofolate. {ECO:0000269|PubMed:8522195}.;
- Pathway
- Antimetabolite Pathway - Folate Cycle, Pharmacodynamics;One carbon pool by folate - Homo sapiens (human);Methotrexate Pathway (Cancer Cell), Pharmacodynamics;Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics;Folate malabsorption, hereditary;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Methotrexate Action Pathway;Folate Metabolism;Folate Metabolism;One Carbon Metabolism;Folate metabolism;Metabolism;folate transformations I;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Vitamin B9 (folate) metabolism
(Consensus)
Recessive Scores
- pRec
- 0.229
Intolerance Scores
- loftool
- 0.547
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.64
Haploinsufficiency Scores
- pHI
- 0.111
- hipred
- N
- hipred_score
- 0.166
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mthfs
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- glutamate metabolic process;folic acid-containing compound biosynthetic process;formate metabolic process;tetrahydrofolate interconversion;tetrahydrofolate metabolic process;folic acid metabolic process;folic acid catabolic process
- Cellular component
- cytoplasm;mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- ATP binding;folic acid binding;5-formyltetrahydrofolate cyclo-ligase activity;metal ion binding